Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia’s Concentriq Dx Attains CE Mark Under IVDR For Use In Primary Diagnosis

Proscia
By Author Proscia | June 8, 2022

Concentriq Dx is the platform of choice for top reference laboratories and health systems in Europe, including LabPON and Uppsala University Hospital.

Read Full Article

Our website uses cookies. By using this site, you agree to its use of cookies.

Agree

Privacy Policy